Pingping Hu

658 total citations
19 papers, 515 citations indexed

About

Pingping Hu is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Pingping Hu has authored 19 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 11 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Pingping Hu's work include Cancer Immunotherapy and Biomarkers (7 papers), Immune cells in cancer (7 papers) and Hepatitis B Virus Studies (4 papers). Pingping Hu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Immune cells in cancer (7 papers) and Hepatitis B Virus Studies (4 papers). Pingping Hu collaborates with scholars based in China, Hong Kong and Denmark. Pingping Hu's co-authors include Jiajun Du, Frede Donskov, Guanghui Wang, Qi Liu, Chuanlong Zhu, Zhaofei Pang, Guodong Deng, Jiandong Zhang, Linhai Zhu and Ping Zhang and has published in prestigious journals such as PLoS ONE, Frontiers in Immunology and Journal of Ethnopharmacology.

In The Last Decade

Pingping Hu

19 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pingping Hu China	10	309	268	107	77	55	19	515
Cody T. Mowery United States	7	262 0.8×	308 1.1×	257 2.4×	55 0.7×	38 0.7×	8	651
Shriram K. Sundararaman United States	6	272 0.9×	210 0.8×	180 1.7×	82 1.1×	79 1.4×	8	506
Filippos Kontos United States	8	153 0.5×	252 0.9×	92 0.9×	51 0.7×	75 1.4×	15	429
Annegé Vledder Netherlands	4	307 1.0×	404 1.5×	139 1.3×	103 1.3×	126 2.3×	9	626
Micaela Morgado United States	9	252 0.8×	366 1.4×	169 1.6×	84 1.1×	126 2.3×	12	641
Antonin Saldmann France	6	205 0.7×	298 1.1×	92 0.9×	25 0.3×	73 1.3×	9	409
Charlene M. Fares United States	5	264 0.9×	430 1.6×	111 1.0×	63 0.8×	106 1.9×	11	546
Priyanka B. Subrahmanyam United States	8	269 0.9×	309 1.2×	104 1.0×	36 0.5×	60 1.1×	14	480
Koen A. Marijt Netherlands	10	480 1.6×	408 1.5×	151 1.4×	52 0.7×	74 1.3×	13	672
Anna Spille Germany	6	436 1.4×	504 1.9×	64 0.6×	52 0.7×	48 0.9×	6	660

Countries citing papers authored by Pingping Hu

Since Specialization

Citations

This map shows the geographic impact of Pingping Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pingping Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pingping Hu more than expected).

Fields of papers citing papers by Pingping Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pingping Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pingping Hu. The network helps show where Pingping Hu may publish in the future.

Co-authorship network of co-authors of Pingping Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Pingping Hu. A scholar is included among the top collaborators of Pingping Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pingping Hu. Pingping Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Wu, Xue, Yiming Mu, Jiandong Zhang, et al.. (2025). The efficacy and safety of adjuvant immunotherapy after neoadjuvant immunotherapy combined with chemotherapy in locally advanced resectable esophageal squamous cell carcinoma: a real−world study. Frontiers in Immunology. 16. 1555756–1555756. 1 indexed citations

Zhang, Yiwen, Liuyang Yang, Junfeng Yang, et al.. (2025). Differentiation of multiple adrenal adenoma subtypes based on a radiomics and clinico-radiological model: a dual-center study. BMC Medical Imaging. 25(1). 45–45. 1 indexed citations

Li, Pan, Ruoyu Zhang, Pingping Hu, Tingting Wang, & Jianwei Wang. (2025). Cepharanthine relieves nonalcoholic steatohepatitis through inhibiting STAT1/CXCL10 axis-mediated lipogenesis and inflammatory responses. Journal of Ethnopharmacology. 341. 119358–119358. 2 indexed citations

Li, Yuwen, Pingping Hu, Hui Yuan, et al.. (2023). Plerixafor and resatorvid inhibit hepatitis B virus in vitro by upregulating elongation factor Tu GTP-binding domain containing 2. Frontiers in Cellular and Infection Microbiology. 13. 1118801–1118801. 2 indexed citations

Hu, Pingping, Yuwen Li, Hui Yuan, et al.. (2023). The Spliceosome Factor EFTUD2 Promotes IFN Anti-HBV Effect through mRNA Splicing. Mediators of Inflammation. 2023. 1–11. 2 indexed citations

Yuan, Meng, Yanan Wu, Lili Qiao, et al.. (2023). Targeting complement C5a to improve radiotherapy sensitivity in non-small cell lung cancer. Translational Lung Cancer Research. 12(5). 1093–1107. 13 indexed citations

Jin, Yun, Pingping Hu, Chao Yang, et al.. (2022). Expression of Id3 represses exhaustion of anti-tumor CD8 T cells in liver cancer. Molecular Immunology. 144. 117–126. 13 indexed citations

Hu, Pingping, et al.. (2021). Advances in HBV infection and replication systems in vitro. Virology Journal. 18(1). 105–105. 29 indexed citations

Liu, Qiqi, Rui Du, Jian Xie, et al.. (2021). Radiotherapy programs neutrophils to an antitumor phenotype by inducing mesenchymal-epithelial transition. Translational Lung Cancer Research. 10(3). 1424–1443. 35 indexed citations

10.

Li, Yuwen, Pingping Hu, Hui Yuan, et al.. (2021). Association of Elongation Factor Tu GTP-binding Domain-containing 2 Gene (EFTUD2) Polymorphism with the Risk of Hepatitis B Virus Infection. Immunological Investigations. 51(5). 1485–1497. 3 indexed citations

11.

Hu, Pingping, et al.. (2020). Genomic analysis of the prognostic effect of tumor-associated neutrophil-related genes across 15 solid cancer types: an immune perspective. Annals of Translational Medicine. 8(22). 1507–1507. 9 indexed citations

12.

Jin, Yun, Pingping Hu, Chao Yang, et al.. (2020). PD-1 expression is elevated in monocytes from hepatocellular carcinoma patients and contributes to CD8 T cell suppression. Immunologic Research. 68(6). 436–444. 16 indexed citations

13.

Li, Lei, Xiaohui Liu, Xiaoye Ma, et al.. (2019). Identification of key candidate genes and pathways in glioblastoma by integrated bioinformatical analysis. Experimental and Therapeutic Medicine. 18(5). 3439–3449. 20 indexed citations

14.

Li, Yuwen, Fei Xiao, Wenting Li, et al.. (2019). Overexpression of Opa interacting protein�5 increases the progression of liver cancer via BMPR2/JUN/CHEK1/RAC1 dysregulation. Oncology Reports. 41(4). 2075–2088. 19 indexed citations

15.

Liu, Qiqi, Pingping Hu, Guodong Deng, et al.. (2017). Soluble cytotoxic T-lymphocyte antigen 4: a favorable predictor in malignant tumors after therapy. OncoTargets and Therapy. Volume 10. 2147–2154. 24 indexed citations

16.

Hu, Pingping, et al.. (2015). Intratumoral neutrophil granulocytes contribute to epithelial-mesenchymal transition in lung adenocarcinoma cells. Tumor Biology. 36(10). 7789–7796. 39 indexed citations

17.

Hu, Pingping, Guanghui Wang, Ping Zhang, et al.. (2015). Intratumoral polymorphonuclear granulocyte is associated with poor prognosis in squamous esophageal cancer by promoting epithelial–mesenchymal transition. Future Oncology. 11(5). 771–783. 9 indexed citations

18.

Hu, Pingping, et al.. (2014). Tumor-Associated Neutrophils as a New Prognostic Factor in Cancer: A Systematic Review and Meta-Analysis. PLoS ONE. 9(6). e98259–e98259. 270 indexed citations

19.

Hu, Pingping, Zhaofei Pang, Hongchang Shen, et al.. (2014). Tumor-infiltrating neutrophils predict poor outcome in adenocarcinoma of the esophagogastric junction. Tumor Biology. 36(4). 2965–2971. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact